-The Times of India MUMBAI: Here's why drug-resistant tuberculosis (TB) breeds freely in Mumbai: Patients don't get appropriate medication. A new study collating information from eight hospitals and treatment centres across Mumbai, Thane and Navi Mumbai found patients were given drugs that they were resistant to. The study, published in PLOS ONE medical journal recently, looked at 340 patients suffering from multi-drug resistant (MDR) TB between 2005 and 2013. "We found only 29.4% of...

-The Telegraph New Delhi: A public health expert has questioned the Indian government's commitment to effectively tackling tuberculosis, citing slashed funds, late diagnoses and a failure to curb incorrect or inappropriate prescriptions by many private practitioners. India's plans to eliminate TB as a public health problem by 2050 will remain unachievable without sustained financial support, strong political will and stringent regulation, Mahavir Golechha has said. Golechha is a faculty member with the health...

-The Times of India NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'. The move is aimed at spanning the...

-The Times of India NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists. For instance, currently only one strength of Paracetamol is under price control, whereas...

-The Telegraph New Delhi: India's health ministry will tomorrow release the country's first-ever rulebook on tuberculosis that medical experts hope will help curb wrong treatment in the private sector and improve results in public-sector clinics. The Standards for TB Care in India (STCI) prescribe ways to diagnose and treat the disease, a bacterial infection that requires multiple drugs to be administered for at least six months - and up to two years...